GLP-1 drugs linked to 17% drop in worker sick leave, new economic study finds
GLP-1 drugs could lead to cost savings for workers and their employers by reducing employee sick leave, a new economic study finds. Researchers found that patients who used the drugs, sold under brand names including Ozempic and Wegovy, took 17% less long-term sick leave than people who didn’t use the medications. The study defines long-term…